{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:45Z","timestamp":1787020425432,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Inflammation is often associated with several bladder dysfunctions, including overactive bladder (OAB) and interstitial cystitis\/bladder pain syndrome (IC\/PBS). As such, inflammation of the bladder and the actions of inflammatory mediators may contribute to the development of urinary symptoms. This study assessed the actions of PGE\n                      <jats:sub>2<\/jats:sub>\n                      , PGF\n                      <jats:sub>2<\/jats:sub>\n                      , PGD\n                      <jats:sub>2<\/jats:sub>\n                      , TXA\n                      <jats:sub>2<\/jats:sub>\n                      , and PGI\n                      <jats:sub>2<\/jats:sub>\n                      on urinary bladder urothelium with lamina propria (U&amp;LP), and detrusor smooth muscle.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies were carried out using isolated tissue baths, where strips of\u00a0porcine bladder U&amp;LP or detrusor were exposed to varying concentrations of prostaglandin agonists (1\u2009\u03bcM and 10\u2009\u03bcM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All assessed prostaglandin agonists contracted both the U&amp;LP and detrusor smooth muscle, with the rank order of contractile response effectiveness as: PGE\n                      <jats:sub>2<\/jats:sub>\n                      \u2009&gt;\u2009PGF\n                      <jats:sub>2\u03b1<\/jats:sub>\n                      \u2009&gt;\u2009TXA\n                      <jats:sub>2<\/jats:sub>\n                      \u2009&gt;\u2009PGD\n                      <jats:sub>2<\/jats:sub>\n                      \u2009&gt;\u2009PGI\n                      <jats:sub>2<\/jats:sub>\n                      . In U&amp;LP, treatment with PGE\n                      <jats:sub>2<\/jats:sub>\n                      (10\u2009\u03bcM) increased tonic contractions by 1.36\u2009\u00b1\u20090.09\u2009g (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200942,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and phasic contractions by 40.4\u2009\u00b1\u20099.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200942,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In response to PGF\n                      <jats:sub>2\u03b1<\/jats:sub>\n                      (10\u2009\u03bcM), U&amp;LP tonic contractions increased by 0.79\u2009\u00b1\u20090.06\u2009g (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and phasic activity by 13.3%\u2009\u00b1\u20095.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In detrusor preparations, PGE\n                      <jats:sub>2<\/jats:sub>\n                      (10\u2009\u03bcM) increased tonic contractions by 1.32\u2009\u00b1\u20090.13\u2009g (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200938,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and PGF\n                      <jats:sub>2\u03b1<\/jats:sub>\n                      (10\u2009\u03bcM) by 0.97\u2009\u00b1\u20090.14\u2009g (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Only 34% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200948) of all detrusor preparations exhibited spontaneous activity prior to the addition of any agonist at a frequency of 2.03\u2009\u00b1\u20090.12\u2009cpm. In preparations that did not exhibit initial phasic activity, all of the prostaglandin agonists were capable of commencing phasic activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The urinary bladder U&amp;LP and detrusor respond to a variety of prostaglandin agonists, with their activation resulting in direct contractions, as well as increases to spontaneous contractile activity. This study presents the prostaglandin receptor system as a potential therapeutic target for lower urinary tract dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-020-00619-0","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T17:16:19Z","timestamp":1588180579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The five primary prostaglandins stimulate contractions and phasic activity of the urinary bladder urothelium, lamina propria and detrusor"],"prefix":"10.1186","volume":"20","author":[{"given":"Zane","family":"Stromberga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ","family":"Chess-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-8301","authenticated-orcid":false,"given":"Christian","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/cs0410069","volume":"41","author":"NJ Gilmore","year":"1971","unstructured":"Gilmore NJ, Vane JR. Hormones released into the circulation when the urinary bladder of the anaesthetized dog is distended. Clin Sci. 1971;41:69\u201383.","journal-title":"Clin Sci"},{"issue":"5","key":"619_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrurol.2012.33","volume":"9","author":"MS Rahnama'i","year":"2012","unstructured":"Rahnama'i MS, van Kerrebroeck PE, de Wachter SG, van Koeveringe GA. The role of prostanoids in urinary bladder physiology. Nat Rev Urol. 2012;9(5):283\u201390.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"619_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.juro.2009.09.071","volume":"183","author":"I Tanaka","year":"2010","unstructured":"Tanaka I, Nagase K, Tanase K, Aoki Y, Akino H, Yokoyama O. Improvement in neurogenic detrusor overactivity by peripheral C fiber's suppression with cyclooxygenase inhibitors. J Urol. 2010;183(2):786\u201392.","journal-title":"J Urol"},{"issue":"5 Pt 2","key":"619_CR4","first-page":"F859","volume":"259","author":"AA Reyes","year":"1990","unstructured":"Reyes AA, Klahr S. Bladder contributes to eicosanoids excreted in urine. Am J Phys. 1990;259(5 Pt 2):F859\u2013F61.","journal-title":"Am J Phys"},{"key":"619_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1442-2042.2005.01140.x","volume":"12","author":"JC Kim","year":"2005","unstructured":"Kim JC. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int J Urol. 2005;12:875\u201380.","journal-title":"Int J Urol"},{"key":"619_CR6","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","volume":"175","author":"JC Kim","year":"2006","unstructured":"Kim JC, Park EY, Seo SI, Park YH, Hwang TK. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol. 2006;175:1773\u20136.","journal-title":"J Urol"},{"issue":"2","key":"619_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1748-1716.1977.tb05933.x","volume":"100","author":"KE Andersson","year":"1977","unstructured":"Andersson KE, Ek A, Persson CG. Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol Scand. 1977;100(2):165\u201371.","journal-title":"Acta Physiol Scand"},{"issue":"5","key":"619_CR8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986\u20131000.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"619_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0952-3278(98)90104-1","volume":"59","author":"MA Khan","year":"1998","unstructured":"Khan MA, Thompson CS, Mumtaz FH, Jeremy JY, Morgan RJ, Mikhailidis DP. Role of prostaglandins in the urinary bladder: an update. Prostaglandins Leukot Essent Fat Acids. 1998;59(6):415\u201322.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"4","key":"619_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.5812\/numonthly.14087","volume":"5","author":"MS Rahnama'i","year":"2013","unstructured":"Rahnama'i MS, Van Koeveringe GA, Van Kerrebroeck PE. Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction. Nephrourol Mon. 2013;5(4):934\u201345.","journal-title":"Nephrourol Mon"},{"key":"619_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/003655902320766006","volume":"210","author":"KE Andersson","year":"2002","unstructured":"Andersson KE. Overactive bladder - pharmacological aspects. Scand J Urol Nephrol Suppl. 2002;210:72\u201381.","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"1","key":"619_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI200113416","volume":"108","author":"SL Tilley","year":"2001","unstructured":"Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001;108(1):15\u201323.","journal-title":"J Clin Invest"},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0065-2776(08)60430-7","volume":"62","author":"WL Smith","year":"1996","unstructured":"Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 1996;62:167\u2013215.","journal-title":"Adv Immunol"},{"key":"619_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1442-2042.2006.01274.x","volume":"13","author":"K Masunaga","year":"2006","unstructured":"Masunaga K. Prostaglandin E2 release from isolated bladder strips in rats with spinal cord injury. Int J Urol. 2006;13:271\u20136.","journal-title":"Int J Urol"},{"key":"619_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1464-410X.1987.tb04575.x","volume":"59","author":"JY Jeremy","year":"1987","unstructured":"Jeremy JY. Eicosanoid synthesis by human urinary bladder mucosa: pathological implications. Br J Urol. 1987;59:36\u20139.","journal-title":"Br J Urol"},{"key":"619_CR16","volume-title":"Australian code for the care and use of animals for scientific purposes","author":"Australia Government","year":"2013","unstructured":"Australia Government. Australian code for the care and use of animals for scientific purposes 2013 [Available from: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/australian-code-care-and-use-animals-scientific-purposes."},{"key":"619_CR17","volume-title":"Using Animals in Science","author":"Queensland Government","year":"2016","unstructured":"Queensland Government. Using Animals in Science 2016 [Available from: https:\/\/www.business.qld.gov.au\/industries\/farms-fishing-forestry\/agriculture\/livestock\/animal-welfare\/animals-science\/activities\/dead-animals."},{"issue":"1","key":"619_CR18","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1038\/s41598-019-40384-1","volume":"9","author":"Z Stromberga","year":"2019","unstructured":"Stromberga Z, Chess-Williams R, Moro C. Histamine modulation of urinary bladder urothelium, lamina propria and detrusor contractile activity via H1 and H2 receptors. Sci Rep. 2019;9(1):3899.","journal-title":"Sci Rep"},{"issue":"1","key":"619_CR19","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1038\/s41598-020-60967-7","volume":"10","author":"Z Stromberga","year":"2020","unstructured":"Stromberga Z, Chess-Williams R, Moro C. Alterations in histamine responses between juvenile and adult urinary bladder urothelium, lamina propria and detrusor tissues. Sci Rep. 2020;10(1):4116.","journal-title":"Sci Rep"},{"issue":"11","key":"619_CR20","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/iju.13172","volume":"23","author":"C Moro","year":"2016","unstructured":"Moro C, Edwards L, Chess-Williams R. 5-HT2A receptor enhancement of contractile activity of the porcine urothelium and lamina propria. Int J Urol. 2016;23(11):946\u201351.","journal-title":"Int J Urol"},{"issue":"3 Pt 4","key":"619_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/aap.12000","volume":"32","author":"C Moro","year":"2012","unstructured":"Moro C, Chess-Williams R. Non-adrenergic, non-cholinergic, non-purinergic contractions of the urothelium\/lamina propria of the pig bladder. Auton Autacoid Pharmacol. 2012;32(3 Pt 4):53\u20139.","journal-title":"Auton Autacoid Pharmacol"},{"issue":"6","key":"619_CR22","doi-asserted-by":"publisher","first-page":"1442.e9","DOI":"10.1016\/j.urology.2011.08.039","volume":"78","author":"C Moro","year":"2011","unstructured":"Moro C, Uchiyama J, Chess-Williams R. Urothelial\/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol. Urology. 2011;78(6):1442.e9\u201315.","journal-title":"Urology"},{"issue":"2\u20133","key":"619_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejphar.2011.11.020","volume":"674","author":"C Moro","year":"2012","unstructured":"Moro C, Leeds C, Chess-Williams R. Contractile activity of the bladder urothelium\/lamina propria and its regulation by nitric oxide. Eur J Pharmacol. 2012;674(2\u20133):445\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"619_CR24","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.juro.2006.11.070","volume":"177","author":"T Lee","year":"2007","unstructured":"Lee T, Hedlund P, Newgreen D, Andersson KE. Urodynamic effects of a novel EP (1) receptor antagonist in normal rats and rats with bladder outlet obstruction. J Urol. 2007;177(4):1562\u20137.","journal-title":"J Urol"},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bjp.0701903","volume":"124","author":"S Palea","year":"1998","unstructured":"Palea S. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. Br J Pharmacol. 1998;124:865\u201372.","journal-title":"Br J Pharmacol"},{"issue":"16","key":"619_CR26","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1111\/bph.13174","volume":"172","author":"NN Guan","year":"2015","unstructured":"Guan NN, Svennersten K, de Verdier PJ, Wiklund NP, Gustafsson LE. Receptors involved in the modulation of Guinea pig urinary bladder motility by prostaglandin D2. Br J Pharmacol. 2015;172(16):4024\u201337.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"619_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1464-410X.1987.tb04575.x","volume":"59","author":"JY Jeremy","year":"1987","unstructured":"Jeremy JY, Tsang V, Mikhailidis DP, Rogers H, Morgan RJ, Dandona P. Eicosanoid synthesis by human urinary bladder mucosa: pathological implications. Br J Urol. 1987;59(1):36\u20139.","journal-title":"Br J Urol"},{"issue":"2","key":"619_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/01.STR.14.2.157","volume":"14","author":"S Moncada","year":"1983","unstructured":"Moncada S. Biology and therapeutic potential of prostacyclin. Stroke. 1983;14(2):157\u201368.","journal-title":"Stroke."}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:32:55Z","timestamp":1619638375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00619-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-17651\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with relevant Australian guidelines and regulations, and all experimental protocols were in accordance the Australian Code of Practice for the Care and Use of Animals for Scientific Purpose [\n                      \n                      ]. As no animals were bred, harmed, culled, interfered, or interacted with as part of this research project, Animal Ethics Approval was not required for offal use [\n                      \n                      ].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}